HeartWare HVAD双心室辅助装置的国际经验
该回顾性研究纳入2009至2017年12个中心的93例HVAD双心室辅助装置患者,1年和2年Kaplan-Meier生存率分别为56%和47%。生存与RVAD植入位置(右心室或右心房)及是否分期植入无关,最常见不良事件为出血(35.5%)、感染(25.8%)和呼吸衰竭(20.4%)。
要点
- HVAD双心室辅助1年和2年生存率分别为56%和47%。
- RVAD植入位置(右心室或右心房)不影响生存和不良事件。
- 最常见不良事件为出血、感染和呼吸衰竭。
核心结论
- HVAD双心室辅助患者1年和2年生存率分别为56%和47%。
- 原期或分期植入HVAD双心室辅助的1年和2年生存相似。
- RVAD植入位置(右心室或右心房)导致相似的不良事件谱。
研究设计与样本
- 回顾性研究,纳入2009至2017年12个中心植入HVAD双心室辅助装置的患者93例。
主要发现
- 93例HVAD双心室辅助患者1年和2年Kaplan-Meier生存率分别为56%和47%。
- 生存与HVAD RVAD植入位置(右心室或右心房)无关。
- 生存与左VAD和RVAD植入之间是否有间隔无关。
- 最常见不良事件为出血(35.5%)、感染(25.8%)和呼吸衰竭(20.4%)。
临床怎么用
- HVAD可用于双心室辅助,原期或分期植入及右心室或右心房植入均可考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart transplantation is limited by the scarcity of suitable donors. Patients with advanced biventricular failure may require biventricular support to provide optimal cardiac output and end-organ perfusion. We highlight the outcomes of using the HeartWare HVAD System (HVAD) in a biventricular configuration. METHODS: This retrospective study included patients implanted with HVAD as a biventricular assist device (BiVAD) between 2009 and 2017 at 12 participating centers. When used as a right ventricular assist device (VAD) (RVAD), the HVAD can be attached to the right ventricle (RV) or the right atrium (RA). Kaplan-Meier survival estimates were calculated comparing the 2 RVAD implant locations. Comparisons were also made between the timing of RVAD implantation (primary vs staged) on adverse event (AE) profiles and survival. RESULTS: Among the 93 patients who were implanted with a HVAD BiVAD, Kaplan-Meier survivals at 1-year and 2-year were 56% and 47%, respectively. Survival was independent of the location of the HVAD RVAD implant or whether there was an interval between left VAD and RVAD implantation. The most common AEs were bleeding (35.5%), infection (25.8%), and respiratory failure (20.4%). CONCLUSIONS: This study illustrated similar survival in patients receiving a primary or staged HVAD BiVAD implant at 1 year and 2 years. This study also established that the locations of the RVAD implant (RV or RA) result in similar AE profiles.
引用
- Marasco S, Simon AR, Tsui S, et al. International experience using a durable, centrifugal-flow ventricular assist device for biventricular support. J Heart Lung Transplant. 2020. PMID: 32917479. doi:10.1016/j.healun.2020.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。